Delayed lupus nephritis

Annals of the Rheumatic Diseases

Volumn 67, Issue 7, 2008, Pages 1044-1046

  Varela, D C ^a,b   Quintana, G ^c   Somers, E C ^d   Rojas Villarraga, A ^a,e   Espinosa, G ^c   Hincapie, M E ^a   McCune, W J ^d   Cervera, R ^c   Anaya, J M ^a,e  

^a Corporación para Investigaciones Biológicas ^*  (Colombia)

^b Clinica Universitaria Bolivariana   (Colombia)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; NEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RISK FACTORS; SJOGREN'S SYNDROME; TIME FACTORS;

EID: 46849094953     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2008.088740     Document Type: Article

References (16)

1. Cervera R, Khamastha MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 1993;72:113-24.
2. Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev 2006;5:180-6.
3. Anaya JM, Uribe M, Perez A, Sanchez JF, Pinto LF, Molina JF, et al. Clinical and immunological factors associated with lupus nephritis in patients from northwestern Colombia. Biomedica 2003;23:293-300.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
5. Fernandez A, Quintana G, Matteson EL, Restrepo JF, Rondon F, Sanchez A, et al. Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clin Rheumatol 2004;23:523-6.
6. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revised Kidney Int 2004;65:521-30.
7. Vitali C, Bombardiert S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
8. Miyakis S, Lockshin MD, Atsumi T, Branch DC, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
9. Manoussakis MN, Georgopoulou C, Zintzaras E. Sjögren's syndrome associated with systemic lupus erythematosus clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum 2004;50:882-91.
10. McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 2000;59:230-2.
11. Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol 1990;17:201-4.
12. Font J, Pallarés L, Cervera R, López-Soto A, Navarro M, Bosch X, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 1991;50:702-5.
13. Anaya JM, Corena R, Castiblanco J, Rojas-Villarraga A, Shoenfeld Y. The kaleidoscope of autoimmunity. Multiple autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol 2007;3:623-35.
14. Paran D, Fireman E, Elkayam O. Pulmonary disease in systemic lupus erythematosus and the antiphospholipid syndrome. Autoimmun Rev 2004;3:70-5.
15. Font J, Ramos-Casals M, Cervera R, Garcia-Carrasco M, Torras A, Siso A, et al. Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 2001;94:19-26.
16. Hill GS, Nochy D. Antiphospholipid syndrome in systemic lupus erythematosus. J Am Soc Nephrol 2007;18:2461-4.